These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33164593)

  • 41. Cost-Effectiveness of Immediate Compared With Delayed Postpartum Etonogestrel Implant Insertion.
    Gariepy AM; Duffy JY; Xu X
    Obstet Gynecol; 2015 Jul; 126(1):47-55. PubMed ID: 26241255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of an implantable steroid contraceptive (etonogestrel-releasing implant) on quality of life and sexual function: a preliminary study.
    Di Carlo C; Sansone A; De Rosa N; Gargano V; Tommaselli GA; Nappi C; Bifulco G
    Gynecol Endocrinol; 2014 Jan; 30(1):53-6. PubMed ID: 24131079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Etonogestrel-releasing contraceptive implant in a patient using thalidomide for the treatment of erythema nodosum leprosum: a case report.
    Ferreira-Filho ES; Bahamondes L; Duarte DC; Guimarães ALM; de Almeida PG; Soares-Júnior JM; Baracat EC; Sorpreso ICE
    Gynecol Endocrinol; 2022 Jan; 38(1):90-93. PubMed ID: 34486922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene expression associated with unfavorable vaginal bleeding in women using the etonogestrel subdermal contraceptive implant: a prospective study.
    Torelli FR; Rodrigues-Peres RM; Monteiro I; Lopes-Cendes I; Bahamondes L; Juliato CRT
    Sci Rep; 2024 May; 14(1):11062. PubMed ID: 38745005
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ongoing Etonogestrel Contraceptive Implant Use Throughout Pregnancy.
    Lazorwitz A; Coleman-Minahan K; Teal SB; Guiahi M
    J Adolesc Health; 2018 Sep; 63(3):363-364. PubMed ID: 30076014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Menstrual bleeding patterns in adolescents using etonogestrel (ENG) implant.
    Deokar AM; Jackson W; Omar HA
    Int J Adolesc Med Health; 2011; 23(1):75-7. PubMed ID: 21721368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postpartum hormonal contraception use and incidence of postpartum depression: a systematic review.
    Ti A; Curtis KM
    Eur J Contracept Reprod Health Care; 2019 Apr; 24(2):109-116. PubMed ID: 30920314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Six- and twelve-month documented removal rates among women electing postpartum inpatient compared to delayed or interval contraceptive implant insertions after Medicaid payment reform.
    Crockett AH; Pickell LB; Heberlein EC; Billings DL; Mills B
    Contraception; 2017 Jan; 95(1):71-76. PubMed ID: 27400823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
    McNicholas C; Swor E; Wan L; Peipert JF
    Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An exploratory study on the possible association of serum etonogestrel concentrations with mood concerns and symptoms among contraceptive implant users.
    Diamond B; Sheeder J; Lazorwitz A
    Contraception; 2024 Jan; 129():110298. PubMed ID: 37802462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of immediate postpartum levonorgestrel contraceptive implant use on breastfeeding and infant growth: a randomized controlled trial.
    Averbach S; Kakaire O; McDiehl R; Dehlendorf C; Lester F; Steinauer J
    Contraception; 2019 Feb; 99(2):87-93. PubMed ID: 30408456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A clinical evaluation of bleeding patterns, adverse effects, and satisfaction with the subdermal etonogestrel implant among postpartum and non-postpartum users.
    Wahab NA; Rahman NA; Mustafa KB; Awang M; Sidek AA; Ros RM
    Int J Gynaecol Obstet; 2016 Feb; 132(2):237-8. PubMed ID: 26617248
    [No Abstract]   [Full Text] [Related]  

  • 53. The Association between Immediate Postpartum Depot Medroxyprogesterone Acetate Use and Postpartum Depressive Symptoms.
    Ross CM; Shim JY; Stark EL; Wisner KL; Miller ES
    Am J Perinatol; 2023 Dec; 40(16):1765-1769. PubMed ID: 34775585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant.
    Moray KV; Chaurasia H; Sachin O; Joshi B
    Reprod Health; 2021 Jan; 18(1):4. PubMed ID: 33407632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Applicability of ancestral genotyping in pharmacogenomic research with hormonal contraception.
    Lazorwitz A; Aquilante CL; Shortt JA; Sheeder J; Teal S; Gignoux CR
    Clin Transl Sci; 2021 Sep; 14(5):1713-1718. PubMed ID: 33650294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Etonogestrel implant use in women primarily choosing a combined oral contraceptive pill: A proof-of-concept trial.
    Chen MJ; Hsia JK; Creinin MD
    Contraception; 2018 Jun; 97(6):533-537. PubMed ID: 29496473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing Weight Status in Adolescent and Young Adult Users of the Etonogestrel Contraceptive Implant.
    Romano ME; Braun-Courville DK
    J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):409-414. PubMed ID: 30928532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Etonogestrel contraceptive implant uptake and safety among solid organ transplant recipients.
    Lew J; Sheeder J; Lazorwitz A
    Contraception; 2021 Nov; 104(5):556-560. PubMed ID: 34147509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medical eligibility criteria for new contraceptive methods: combined hormonal patch, combined hormonal vaginal ring and the etonogestrel implant.
    Gaffield ME; Curtis KM; Mohllajee AP; Peterson HB
    Contraception; 2006 Feb; 73(2):134-44. PubMed ID: 16413844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.